id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT03145181 | 53:69:cancer | exhibits clinical signs of meningeal involvement of multiple myeloma | 2 | [
"exhibits",
"clinical",
"signs",
"of",
"meningeal",
"involvement",
"of",
"multiple",
"myeloma"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT03096366 | 1:110:treatment | Anterior cruciate ligament (ACL) reconstruction with concomitant meniscus or cartilage restoration procedures | 2 | [
"Anterior",
"cruciate",
"ligament",
"(",
"ACL",
")",
"reconstruction",
"with",
"concomitant",
"meniscus",
"or",
"cartilage",
"restoration",
"procedures"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT01313533 | 34:43:chronic_disease | Subject has clinical evidence of infection that the Investigator deems significant to the completion of the procedure or that could compromise the subject's safety | 2 | [
"Subject",
"has",
"clinical",
"evidence",
"of",
"infection",
"that",
"the",
"Investigator",
"deems",
"significant",
"to",
"the",
"completion",
"of",
"the",
"procedure",
"or",
"that",
"could",
"compromise",
"the",
"subject",
"'s",
"safety"
] | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01494662 | 14:34:chronic_disease,76:92:chronic_disease,106:130:chronic_disease,132:156:chronic_disease,158:176:chronic_disease,181:218:chronic_disease | Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements | 2 | [
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or"... | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02446236 | 49:58:chronic_disease | Patients may be eligible upon resolution of the infection | 2 | [
"Patients",
"may",
"be",
"eligible",
"upon",
"resolution",
"of",
"the",
"infection"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02025465 | 1:7:chronic_disease | Asthma | 2 | [
"Asthma"
] | [
2
] |
NCT01807091 | 27:57:treatment | The benefits/risks of the induction chemotherapy regimen will be reviewed | 2 | [
"The",
"benefits/risks",
"of",
"the",
"induction",
"chemotherapy",
"regimen",
"will",
"be",
"reviewed"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0
] |
NCT02236013 | 1:20:treatment,25:42:chronic_disease,48:59:treatment, | Emergency treatment for hyperleukocytosis with hydroxyurea for ≤ 10 days | 2 | [
"Emergency",
"treatment",
"for",
"hyperleukocytosis",
"with",
"hydroxyurea",
"for",
"≤",
"10",
"days"
] | [
1,
1,
0,
2,
0,
1,
0,
0,
0,
0
] |
NCT02448381 | 44:68:cancer | Subjects must have a clinical diagnosis of CTCL (mycosis fungoides), Stage IA, Stage IB, or Stage IIA | 2 | [
"Subjects",
"must",
"have",
"a",
"clinical",
"diagnosis",
"of",
"CTCL",
"(",
"mycosis",
"fungoides",
")",
",",
"Stage",
"IA",
",",
"Stage",
"IB",
",",
"or",
"Stage",
"IIA"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03123068 | 1:19:chronic_disease | Infectious disease within the last month | 2 | [
"Infectious",
"disease",
"within",
"the",
"last",
"month"
] | [
2,
2,
0,
0,
0,
0
] |
NCT02457832 | 12:18:chronic_disease | History of stroke | 2 | [
"History",
"of",
"stroke"
] | [
0,
0,
2
] |
NCT02995330 | 1:14:treatment,36:52:treatment,70:82:treatment,84:94:treatment,96:105:treatment,107:119:treatment,121:132:treatment,134:146:treatment,148:155:treatment | Prior therapy with one second line hormonal therapy is allowed (i.e. bicalutamide, nilutamide, flutamide, ketoconazole, abiraterone, enzalutamide, ARN-509) | 2 | [
"Prior",
"therapy",
"with",
"one",
"second",
"line",
"hormonal",
"therapy",
"is",
"allowed",
"(",
"i.e",
".",
"bicalutamide",
",",
"nilutamide",
",",
"flutamide",
",",
"ketoconazole",
",",
"abiraterone",
",",
"enzalutamide",
",",
"ARN-509",
")"
] | [
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT02881242 | 1:20:chronic_disease, | Uncontrolled angina within 3 months | 2 | [
"Uncontrolled",
"angina",
"within",
"3",
"months"
] | [
2,
2,
0,
0,
0
] |
NCT02562235 | 8:44:chronic_disease,46:52:chronic_disease,58:67:chronic_disease | Severe congenital abnormalities of the lung, thorax, and diaphragm | 2 | [
"Severe",
"congenital",
"abnormalities",
"of",
"the",
"lung",
",",
"thorax",
",",
"and",
"diaphragm"
] | [
0,
2,
2,
2,
2,
2,
0,
2,
0,
0,
2
] |
NCT02335242 | 1:17:treatment | Organic nitrates in any form, either regularly or intermittently | 2 | [
"Organic",
"nitrates",
"in",
"any",
"form",
",",
"either",
"regularly",
"or",
"intermittently"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01409161 | ,,,101:109:cancer,139:148:chronic_disease,162:169:chronic_disease | Patients with creatinine > 2.5 times upper limit of normal unless felt to be related the underlying leukemia by the treating physician or hemolysis or Gilbert's disease | 2 | [
"Patients",
"with",
"creatinine",
">",
"2.5",
"times",
"upper",
"limit",
"of",
"normal",
"unless",
"felt",
"to",
"be",
"related",
"the",
"underlying",
"leukemia",
"by",
"the",
"treating",
"physician",
"or",
"hemolysis",
"or",
"Gilbert",
"'s",
"disease"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
2,
0,
0,
0,
2
] |
NCT02634957 | 15:55:chronic_disease | Patients with benign mid membranous vocal fold lesions | 2 | [
"Patients",
"with",
"benign",
"mid",
"membranous",
"vocal",
"fold",
"lesions"
] | [
0,
0,
2,
2,
2,
2,
2,
2
] |
NCT01896921 | 69:80:treatment | Subject requires or is anticipated to require any of the prohibited medications noted in the protocol | 2 | [
"Subject",
"requires",
"or",
"is",
"anticipated",
"to",
"require",
"any",
"of",
"the",
"prohibited",
"medications",
"noted",
"in",
"the",
"protocol"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02417701 | 10:53:treatment,94:105:treatment,,155:165:treatment | Patients receiving histamine H2 receptor antagonists before enrollment must stop using these medications for at least 24 hours before their first dose of study drug | 2 | [
"Patients",
"receiving",
"histamine",
"H2",
"receptor",
"antagonists",
"before",
"enrollment",
"must",
"stop",
"using",
"these",
"medications",
"for",
"at",
"least",
"24",
"hours",
"before",
"their",
"first",
"dose",
"of",
"study",
"drug"
] | [
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02588326 | 1:16:chronic_disease, | Acute sinusitis within the last six weeks prior to enrollment | 2 | [
"Acute",
"sinusitis",
"within",
"the",
"last",
"six",
"weeks",
"prior",
"to",
"enrollment"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01130077 | 74:87:treatment,,128:159:treatment,163:198:treatment,,241:278:treatment | Patients on Strata C and D must have recovered from the toxic effects of prior therapy: at least 3 weeks form the last dose of standard cytotoxic chemotherapy or myelosuppressive biological therapy and at least 1 week from the last dose of non-myelosuppressive biologic therapy | 2 | [
"Patients",
"on",
"Strata",
"C",
"and",
"D",
"must",
"have",
"recovered",
"from",
"the",
"toxic",
"effects",
"of",
"prior",
"therapy",
":",
"at",
"least",
"3",
"weeks",
"form",
"the",
"last",
"dose",
"of",
"standard",
"cytotoxic",
"chemotherapy",
"or",
"my... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01734512 | 44:68:chronic_disease,116:126:treatment,134:152:chronic_disease,167:173:chronic_disease,175:183:chronic_disease,185:193:chronic_disease,195:217:chronic_disease,221:242:treatment | Impairment of gastrointestinal function or gastrointestinal disease that may significantly alter the absorption of everolimus (e.g., ulcerative disease, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome or small bowel resection | 2 | [
"Impairment",
"of",
"gastrointestinal",
"function",
"or",
"gastrointestinal",
"disease",
"that",
"may",
"significantly",
"alter",
"the",
"absorption",
"of",
"everolimus",
"(",
"e.g.",
",",
"ulcerative",
"disease",
",",
"uncontrolled",
"nausea",
",",
"vomiting",
",",... | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
2,
2,
0,
0,
2,
0,
2,
0,
2,
0,
2,
2,
0,
1,
1,
1
] |
NCT02338232 | 1:35:cancer | Acute myeloid or lymphoid leukemia in remission | 2 | [
"Acute",
"myeloid",
"or",
"lymphoid",
"leukemia",
"in",
"remission"
] | [
3,
3,
3,
3,
3,
0,
0
] |
NCT02041936 | 13:31:cancer, | Evidence of distant metastases of stage IV | 2 | [
"Evidence",
"of",
"distant",
"metastases",
"of",
"stage",
"IV"
] | [
0,
0,
3,
3,
0,
0,
0
] |
NCT02575404 | 15:50:cancer,60:69:treatment,75:88:treatment | Patients with metastatic or unresectable melanoma for whom treatment with pembrolizumab is indicated | 2 | [
"Patients",
"with",
"metastatic",
"or",
"unresectable",
"melanoma",
"for",
"whom",
"treatment",
"with",
"pembrolizumab",
"is",
"indicated"
] | [
0,
0,
3,
3,
3,
3,
0,
0,
1,
0,
1,
0,
0
] |
NCT01026532 | ,,,118:130:treatment,,,,,, | Women of child-bearing potential (WCBP) must have a negative urine pregnancy test (urine HCG) within 48 hours of the methacholine challenge at Visit 2, within 48 hours of the inhaled allergen challenge at V3 and on the day of the segmental allergen challenge on Visit 5. WCBP must agree to use a reliable method of birth... | 2 | [
"Women",
"of",
"child-bearing",
"potential",
"(",
"WCBP",
")",
"must",
"have",
"a",
"negative",
"urine",
"pregnancy",
"test",
"(",
"urine",
"HCG",
")",
"within",
"48",
"hours",
"of",
"the",
"methacholine",
"challenge",
"at",
"Visit",
"2",
",",
"within",
"4... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02250664 | 1:18:chronic_disease | Suicidal ideation in the past month | 2 | [
"Suicidal",
"ideation",
"in",
"the",
"past",
"month"
] | [
2,
2,
0,
0,
0,
0
] |
NCT02911792 | 1:35:chronic_disease | Proliferative diabetic retinopathy | 2 | [
"Proliferative",
"diabetic",
"retinopathy"
] | [
2,
2,
2
] |
NCT02133196 | 12:33:cancer,50:76:cancer,107:130:cancer,132:155:cancer,160:175:cancer, | Measurable metastatic (stage IV) or unresectable non-small cell lung cancer (including but not limited to squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinomas) with at least one lesion that is resectable for TIL generation | 2 | [
"Measurable",
"metastatic",
"(",
"stage",
"IV",
")",
"or",
"unresectable",
"non-small",
"cell",
"lung",
"cancer",
"(",
"including",
"but",
"not",
"limited",
"to",
"squamous",
"cell",
"carcinoma",
",",
"adenosquamous",
"carcinoma",
",",
"or",
"adenocarcinomas",
"... | [
0,
3,
3,
3,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02347111 | 1:28:treatment, | Cardiac or thoracic surgery within the previous 6 months | 2 | [
"Cardiac",
"or",
"thoracic",
"surgery",
"within",
"the",
"previous",
"6",
"months"
] | [
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03101956 | 1:13:chronic_disease | Osteoporosis or recent fracture of the hip or spinal joints | 2 | [
"Osteoporosis",
"or",
"recent",
"fracture",
"of",
"the",
"hip",
"or",
"spinal",
"joints"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02427581 | 10:22:treatment,24:36:treatment,41:57:treatment,,83:107:treatment | Received chemotherapy, radiotherapy, or biologic therapy within the last 30 days (neoadjuvant chemotherapy excluded) | 2 | [
"Received",
"chemotherapy",
",",
"radiotherapy",
",",
"or",
"biologic",
"therapy",
"within",
"the",
"last",
"30",
"days",
"(",
"neoadjuvant",
"chemotherapy",
"excluded",
")"
] | [
0,
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT02006069 | 1:16:chronic_disease, | unstable angina within 40 days prior the enrollment | 2 | [
"unstable",
"angina",
"within",
"40",
"days",
"prior",
"the",
"enrollment"
] | [
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT03153319 | 8:33:chronic_disease | Active graft versus host disease | 2 | [
"Active",
"graft",
"versus",
"host",
"disease"
] | [
0,
2,
2,
2,
2
] |
NCT01841333 | 7:20:chronic_disease | Known HIV infection | 2 | [
"Known",
"HIV",
"infection"
] | [
0,
2,
2
] |
NCT01804634 | 52:66:treatment | Patients who relapse after either single or tandem autologous BMT are eligible | 2 | [
"Patients",
"who",
"relapse",
"after",
"either",
"single",
"or",
"tandem",
"autologous",
"BMT",
"are",
"eligible"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT02146924 | 1:20:chronic_disease | Infectious diseases: no clinical evidence of uncontrolled active infectious process | 2 | [
"Infectious",
"diseases",
":",
"no",
"clinical",
"evidence",
"of",
"uncontrolled",
"active",
"infectious",
"process"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02514083 | 42:64:chronic_disease,101:112:chronic_disease,114:151:chronic_disease,236:257:chronic_disease,261:276:chronic_disease,281:304:chronic_disease, | Currently active, clinically significant cardiovascular disease such as uncontrolled or symptomatic arrhythmias, Class 3 or 4 congestive heart failure as defined by New York Heart Association Functional Classification, or a history of myocardial infarction or unstable angina, or acute coronary syndrome within 6 months ... | 2 | [
"Currently",
"active",
",",
"clinically",
"significant",
"cardiovascular",
"disease",
"such",
"as",
"uncontrolled",
"or",
"symptomatic",
"arrhythmias",
",",
"Class",
"3",
"or",
"4",
"congestive",
"heart",
"failure",
"as",
"defined",
"by",
"New",
"York",
"Heart",
... | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02187198 | 11:31:treatment | ever used heroin intravenously | 2 | [
"ever",
"used",
"heroin",
"intravenously"
] | [
0,
0,
1,
1
] |
NCT00001651 | 70:83:chronic_disease | Willingness to allow stored samples to be used for future studies of HIV infection and/or immunological function, and willingness to have HLA typing performed. (For previously enrolled patients, patients would be requested, but not required, to provide permission to use stored samples in the future, and to permit HLA t... | 2 | [
"Willingness",
"to",
"allow",
"stored",
"samples",
"to",
"be",
"used",
"for",
"future",
"studies",
"of",
"HIV",
"infection",
"and/or",
"immunological",
"function",
",",
"and",
"willingness",
"to",
"have",
"HLA",
"typing",
"performed",
".",
"(",
"For",
"previou... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02581384 | 1:7:cancer, | Lesion larger than 3 cm in diameter | 2 | [
"Lesion",
"larger",
"than",
"3",
"cm",
"in",
"diameter"
] | [
3,
0,
0,
0,
0,
0,
0
] |
NCT02418195 | 12:30:chronic_disease | Autoimmune glomerulonephritis | 2 | [
"Autoimmune",
"glomerulonephritis"
] | [
0,
2
] |
NCT02417415 | 13:20:chronic_disease,22:27:chronic_disease,31:46:chronic_disease | Significant cardiac, renal or hepatic illness | 2 | [
"Significant",
"cardiac",
",",
"renal",
"or",
"hepatic",
"illness"
] | [
0,
2,
0,
2,
0,
2,
2
] |
NCT02270619 | 18:35:chronic_disease | prior or current suicidal ideation assessed by the Columbia Suicide Severity Rating Scale (C-SSRS) | 2 | [
"prior",
"or",
"current",
"suicidal",
"ideation",
"assessed",
"by",
"the",
"Columbia",
"Suicide",
"Severity",
"Rating",
"Scale",
"(",
"C-SSRS",
")"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00930228 | 10:13:treatment | Abnormal TSH | 2 | [
"Abnormal",
"TSH"
] | [
0,
1
] |
NCT02746458 | 22:28:cancer | Current diagnosis of cancer | 2 | [
"Current",
"diagnosis",
"of",
"cancer"
] | [
0,
0,
0,
3
] |
NCT02585973 | 27:30:treatment | Prior to study entry, any ECG abnormality at Screening has to be documented by the investigator as not medically relevant | 2 | [
"Prior",
"to",
"study",
"entry",
",",
"any",
"ECG",
"abnormality",
"at",
"Screening",
"has",
"to",
"be",
"documented",
"by",
"the",
"investigator",
"as",
"not",
"medically",
"relevant"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00338377 | 40:56:chronic_disease | Many patients present with concomitant systemic disease outside of the central nervous system | 2 | [
"Many",
"patients",
"present",
"with",
"concomitant",
"systemic",
"disease",
"outside",
"of",
"the",
"central",
"nervous",
"system"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02886572 | 3:29:treatment,, | A contrast-enhanced MRI scan showing = or > 4 brain metastases | 2 | [
"A",
"contrast-enhanced",
"MRI",
"scan",
"showing",
"=",
"or",
">",
"4",
"brain",
"metastases"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02942095 | 80:118:allergy_name,123:133:allergy_name,140:165:allergy_name | Have a known immediate or delayed hypersensitivity reaction or idiosyncrasy to drugs chemically related to study drug, or excipients or to dimethyl sulfoxide (DMSO) | 2 | [
"Have",
"a",
"known",
"immediate",
"or",
"delayed",
"hypersensitivity",
"reaction",
"or",
"idiosyncrasy",
"to",
"drugs",
"chemically",
"related",
"to",
"study",
"drug",
",",
"or",
"excipients",
"or",
"to",
"dimethyl",
"sulfoxide",
"(",
"DMSO",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
4,
4,
4,
4,
4,
0,
0,
4,
0,
0,
4,
4,
4,
0,
0
] |
NCT02990481 | 29:32:chronic_disease,34:45:chronic_disease,47:58:chronic_disease | Known active infection with HIV, hepatitis B, hepatitis C | 2 | [
"Known",
"active",
"infection",
"with",
"HIV",
",",
"hepatitis",
"B",
",",
"hepatitis",
"C"
] | [
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0
] |
NCT02152254 | 18:32:chronic_disease | prior or current cardiomyopathy | 2 | [
"prior",
"or",
"current",
"cardiomyopathy"
] | [
0,
0,
0,
2
] |
NCT02382549 | 30:62:cancer | Participants with measurable stage IIIB, IIIC, or IV melanoma that have clinical or radiological evidence of disease | 2 | [
"Participants",
"with",
"measurable",
"stage",
"IIIB",
",",
"IIIC",
",",
"or",
"IV",
"melanoma",
"that",
"have",
"clinical",
"or",
"radiological",
"evidence",
"of",
"disease"
] | [
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02422641 | 1:16:cancer | Triple-negative patients will be defined per ASCO-CAP Guidelines (American Society of Clinical Oncology-College of American Pathologists) | 2 | [
"Triple-negative",
"patients",
"will",
"be",
"defined",
"per",
"ASCO-CAP",
"Guidelines",
"(",
"American",
"Society",
"of",
"Clinical",
"Oncology-College",
"of",
"American",
"Pathologists",
")"
] | [
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02356705 | 23:47:treatment | scheduled for a minor Ear/Nose/Throat surgical procedure requiring mask anesthesia | 2 | [
"scheduled",
"for",
"a",
"minor",
"Ear/Nose/Throat",
"surgical",
"procedure",
"requiring",
"mask",
"anesthesia"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT02080221 | 1:11:cancer | Metastatic advanced disease | 2 | [
"Metastatic",
"advanced",
"disease"
] | [
3,
0,
0
] |
NCT03073785 | 5:14:cancer | All malignant disease must be able to be encompassed within a single irradiation field | 2 | [
"All",
"malignant",
"disease",
"must",
"be",
"able",
"to",
"be",
"encompassed",
"within",
"a",
"single",
"irradiation",
"field"
] | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03011567 | ,,57:75:treatment | Low platelet count (recorded measurement <50,000 during hospital admission) | 2 | [
"Low",
"platelet",
"count",
"(",
"recorded",
"measurement",
"<",
"50,000",
"during",
"hospital",
"admission",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02836574 | 123:126:chronic_disease | The subject should have adequate, historical clinical data to provide a reasonable estimate of the rate of progression of CKD | 2 | [
"The",
"subject",
"should",
"have",
"adequate",
",",
"historical",
"clinical",
"data",
"to",
"provide",
"a",
"reasonable",
"estimate",
"of",
"the",
"rate",
"of",
"progression",
"of",
"CKD"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT01185132 | 1:4:chronic_disease,, | PTV to ipsilateral breast ratio (IBR) ≤ 25 % | 2 | [
"PTV",
"to",
"ipsilateral",
"breast",
"ratio",
"(",
"IBR",
")",
"≤",
"25",
"%"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03115463 | 22:55:chronic_disease | Prenatally diagnosed cyanotic congenital heart disease | 2 | [
"Prenatally",
"diagnosed",
"cyanotic",
"congenital",
"heart",
"disease"
] | [
0,
0,
2,
2,
2,
2
] |
NCT02584309 | 25:47:treatment | Currently receiving any investigational agents | 2 | [
"Currently",
"receiving",
"any",
"investigational",
"agents"
] | [
0,
0,
0,
1,
1
] |
NCT02460692 | 68:84:chronic_disease | Presence of another painful condition of greater severity than the neuropathic pain condition which is being studied | 2 | [
"Presence",
"of",
"another",
"painful",
"condition",
"of",
"greater",
"severity",
"than",
"the",
"neuropathic",
"pain",
"condition",
"which",
"is",
"being",
"studied"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02875301 | 7:24:chronic_disease | other cardiac condition in the past year | 2 | [
"other",
"cardiac",
"condition",
"in",
"the",
"past",
"year"
] | [
0,
2,
2,
0,
0,
0,
0
] |
NCT02477839 | 43:67:chronic_disease | Subject has a hemodynamically significant congenital heart disease | 2 | [
"Subject",
"has",
"a",
"hemodynamically",
"significant",
"congenital",
"heart",
"disease"
] | [
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01967823 | 76:98:treatment | Patients who have decreased immunecompetence may be less responsive to the experimental treatment and more susceptible to its toxicities | 2 | [
"Patients",
"who",
"have",
"decreased",
"immunecompetence",
"may",
"be",
"less",
"responsive",
"to",
"the",
"experimental",
"treatment",
"and",
"more",
"susceptible",
"to",
"its",
"toxicities"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT03096288 | 1:26:chronic_disease | transient ischemic attack | 2 | [
"transient",
"ischemic",
"attack"
] | [
2,
2,
2
] |
NCT02366611 | 49:55:cancer | Patients are actively being treated for another cancer at the time of enrollment | 2 | [
"Patients",
"are",
"actively",
"being",
"treated",
"for",
"another",
"cancer",
"at",
"the",
"time",
"of",
"enrollment"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT01037790 | 1:29:cancer,47:51:cancer,55:68:cancer | Metastatic colorectal cancer that harbors the Kras or BRAF mutation (15-30 enrollment slots) | 2 | [
"Metastatic",
"colorectal",
"cancer",
"that",
"harbors",
"the",
"Kras",
"or",
"BRAF",
"mutation",
"(",
"15-30",
"enrollment",
"slots",
")"
] | [
3,
3,
3,
0,
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0
] |
NCT02438995 | 51:85:cancer,87:110:cancer,122:143:cancer,148:172:cancer | Patients with a documented diagnosis of recurrent head and neck squamous cell cancer (squamous cell carcinoma, including nasopharyngeal cancer, or adenoid cystic carcinoma) | 2 | [
"Patients",
"with",
"a",
"documented",
"diagnosis",
"of",
"recurrent",
"head",
"and",
"neck",
"squamous",
"cell",
"cancer",
"(",
"squamous",
"cell",
"carcinoma",
",",
"including",
"nasopharyngeal",
"cancer",
",",
"or",
"adenoid",
"cystic",
"carcinoma",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
3,
3,
3,
0
] |
NCT01087294 | 1:16:treatment,69:72:cancer,74:89:cancer,111:120:cancer,125:154:cancer | Prior (DCI) DLI is not an eligibility requirement for patients with ALL, Burkitt lyphoma, ALL like high-grade lymphomas, or diffuse large B-cell lymphoma | 2 | [
"Prior",
"(",
"DCI",
")",
"DLI",
"is",
"not",
"an",
"eligibility",
"requirement",
"for",
"patients",
"with",
"ALL",
",",
"Burkitt",
"lyphoma",
",",
"ALL",
"like",
"high-grade",
"lymphomas",
",",
"or",
"diffuse",
"large",
"B-cell",
"lymphoma"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
3,
0,
0,
3,
3,
3,
3
] |
NCT03026816 | 24:38:chronic_disease | Clinically significant mental illness | 2 | [
"Clinically",
"significant",
"mental",
"illness"
] | [
0,
0,
2,
2
] |
NCT02872935 | 1:11:treatment, | Antiemetic drug use in the 24 hours prior to cesarean delivery | 2 | [
"Antiemetic",
"drug",
"use",
"in",
"the",
"24",
"hours",
"prior",
"to",
"cesarean",
"delivery"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02535832 | 1:19:chronic_disease | Bleeding diathesis | 2 | [
"Bleeding",
"diathesis"
] | [
2,
2
] |
NCT00875342 | 42:55:chronic_disease | Significant health impairment, including renal disease | 2 | [
"Significant",
"health",
"impairment",
",",
"including",
"renal",
"disease"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT02339922 | 1:21:treatment,23:35:treatment,37:47:treatment,49:58:treatment,61:73:treatment,75:95:treatment,97:118:treatment,120:130:treatment,132:143:treatment,146:172:treatment,174:183:treatment,185:198:treatment,200:210:treatment,213:224:treatment,226:241:treatment,297:302:cancer | anti-CD20 antibodies (obinutuzumab, ofatumumab, rituximab); lenalidomide; ibritumomab tiuxetan; proteasome inhibitors (bortezomib, carfilzomib); tyrosine kinase inhibitors (ibrutinib, acalabrutinib, idelalisib); alemtuzumab; corticosteroids unless given for an indication other than treating the B-NHL | 2 | [
"anti-CD20",
"antibodies",
"(",
"obinutuzumab",
",",
"ofatumumab",
",",
"rituximab",
")",
";",
"lenalidomide",
";",
"ibritumomab",
"tiuxetan",
";",
"proteasome",
"inhibitors",
"(",
"bortezomib",
",",
"carfilzomib",
")",
";",
"tyrosine",
"kinase",
"inhibitors",
"("... | [
1,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
0,
1,
1,
0,
1,
1,
0,
1,
0,
1,
0,
0,
1,
1,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02304458 | 1:64:treatment,73:151:treatment,83:91:treatment,,196:228:chronic_disease,252:269:treatment | Allogeneic (non-autologous) bone marrow or stem cell transplant, or any stem cell infusion including donor lymphocyte infusion (DLI) or boost infusion: >= 100 days after infusion, no evidence of graft versus host disease (GVHD) and no requirement for immunosuppression | 2 | [
"Allogeneic",
"(",
"non-autologous",
")",
"bone",
"marrow",
"or",
"stem",
"cell",
"transplant",
",",
"or",
"any",
"stem",
"cell",
"infusion",
"including",
"donor",
"lymphocyte",
"infusion",
"(",
"DLI",
")",
"or",
"boost",
"infusion",
":",
">",
"=",
"100",
... | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
1
] |
NCT02629120 | 14:30:chronic_disease | Uncontrolled seizure disorder | 2 | [
"Uncontrolled",
"seizure",
"disorder"
] | [
0,
2,
2
] |
NCT02580604 | ,,,,,,194:219:treatment | Serum calcium <8.5 or >10.3 mg/dL Serum 25(OH)D <20 ng/mL; volunteers with abnormal serum 25(OH)D values may be re-considered for participation in the study if serum 25(OH)D is >20 ng/mL after vitamin D supplementation | 2 | [
"Serum",
"calcium",
"<",
"8.5",
"or",
">",
"10.3",
"mg/dL",
"Serum",
"25",
"(",
"OH",
")",
"D",
"<",
"20",
"ng/mL",
";",
"volunteers",
"with",
"abnormal",
"serum",
"25",
"(",
"OH",
")",
"D",
"values",
"may",
"be",
"re-considered",
"for",
"participation... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01626079 | 44:47:treatment | Subjects who have any contraindications to CPX and are not capable of performing CPX per investigator's assessment should not be registered in the CPX Sub-study | 2 | [
"Subjects",
"who",
"have",
"any",
"contraindications",
"to",
"CPX",
"and",
"are",
"not",
"capable",
"of",
"performing",
"CPX",
"per",
"investigator",
"'s",
"assessment",
"should",
"not",
"be",
"registered",
"in",
"the",
"CPX",
"Sub-study"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02624765 | 1:15:chronic_disease | cardiomyopathy | 2 | [
"cardiomyopathy"
] | [
2
] |
NCT02495168 | 16:22:chronic_disease | Diagnosed with asthma as defined by the NAEPP 3 | 2 | [
"Diagnosed",
"with",
"asthma",
"as",
"defined",
"by",
"the",
"NAEPP",
"3"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT00670358 | 13:29:chronic_disease | No comorbid systemic illness or other severe concurrent disease that, in the judgment of the investigator, would preclude study entry or significantly interfere with the proper assessment of safety and toxicity of the prescribed study regimen | 2 | [
"No",
"comorbid",
"systemic",
"illness",
"or",
"other",
"severe",
"concurrent",
"disease",
"that",
",",
"in",
"the",
"judgment",
"of",
"the",
"investigator",
",",
"would",
"preclude",
"study",
"entry",
"or",
"significantly",
"interfere",
"with",
"the",
"proper",... | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02561104 | 91:100:treatment,120:140:chronic_disease,151:169:chronic_disease,171:194:chronic_disease,196:205:chronic_disease,207:226:chronic_disease | Subject eyes will lack other pre‐existing ocular pathology or condition that may confound treatment effects, including diabetic retinopathy, previous retinal detachment, iris neovascularization, amblyopia, optic nerve atrophy or recurrent severe anterior or posterior segment inflammation of unknown etiology | 2 | [
"Subject",
"eyes",
"will",
"lack",
"other",
"pre‐existing",
"ocular",
"pathology",
"or",
"condition",
"that",
"may",
"confound",
"treatment",
"effects",
",",
"including",
"diabetic",
"retinopathy",
",",
"previous",
"retinal",
"detachment",
",",
"iris",
"neovasculari... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
2,
2,
0,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02520778 | 27:35:treatment, | must discontinue previous EGFR-TKI at least 7 days prior to study enrollment | 2 | [
"must",
"discontinue",
"previous",
"EGFR-TKI",
"at",
"least",
"7",
"days",
"prior",
"to",
"study",
"enrollment"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01943851 | 36:53:chronic_disease,87:98:chronic_disease,100:107:chronic_disease,109:114:chronic_disease,116:131:chronic_disease,159:176:chronic_disease | Evidence of severe or uncontrolled systemic diseases (e.g., unstable or uncompensated respiratory, hepatic, renal, cardiac disease, or clinically significant bleeding episodes) | 2 | [
"Evidence",
"of",
"severe",
"or",
"uncontrolled",
"systemic",
"diseases",
"(",
"e.g.",
",",
"unstable",
"or",
"uncompensated",
"respiratory",
",",
"hepatic",
",",
"renal",
",",
"cardiac",
"disease",
",",
"or",
"clinically",
"significant",
"bleeding",
"episodes",
... | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0
] |
NCT03069469 | 7:35:chronic_disease,44:55:chronic_disease,64:75:chronic_disease,87:123:chronic_disease | Known human immunodeficiency virus, active hepatitis B, active hepatitis C, or active mycobacterium tuberculosis infection | 2 | [
"Known",
"human",
"immunodeficiency",
"virus",
",",
"active",
"hepatitis",
"B",
",",
"active",
"hepatitis",
"C",
",",
"or",
"active",
"mycobacterium",
"tuberculosis",
"infection"
] | [
0,
2,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02589353 | 13:25:chronic_disease,27:39:chronic_disease,44:53:chronic_disease | has current oral lesions, canker sores, or piercings | 2 | [
"has",
"current",
"oral",
"lesions",
",",
"canker",
"sores",
",",
"or",
"piercings"
] | [
0,
0,
2,
2,
0,
2,
2,
0,
0,
2
] |
NCT02484404 | 23:34:treatment | Patients who have had prior PARPi are not eligible | 2 | [
"Patients",
"who",
"have",
"had",
"prior",
"PARPi",
"are",
"not",
"eligible"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02501473 | 1:4:treatment,48:58:chronic_disease,62:70:chronic_disease | ECG without evidence of clinically significant arrhythmia or ischemia | 2 | [
"ECG",
"without",
"evidence",
"of",
"clinically",
"significant",
"arrhythmia",
"or",
"ischemia"
] | [
1,
0,
0,
0,
0,
0,
2,
0,
2
] |
NCT02876510 | 1:14:chronic_disease | HIV infection | 2 | [
"HIV",
"infection"
] | [
2,
2
] |
NCT02253316 | 51:67:cancer | Histologically confirmed diagnosis of symptomatic multiple myeloma | 2 | [
"Histologically",
"confirmed",
"diagnosis",
"of",
"symptomatic",
"multiple",
"myeloma"
] | [
0,
0,
0,
0,
0,
3,
3
] |
NCT00044304 | 31:43:chronic_disease | no secondary etiology for the eosinophilia despite careful clinical evaluation | 2 | [
"no",
"secondary",
"etiology",
"for",
"the",
"eosinophilia",
"despite",
"careful",
"clinical",
"evaluation"
] | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT03114501 | 26:29:cancer | Diagnosed with a primary HNC | 2 | [
"Diagnosed",
"with",
"a",
"primary",
"HNC"
] | [
0,
0,
0,
0,
3
] |
NCT02475707 | 5:13:cancer,112:126:treatment,132:147:treatment | Any leukemia-specific marker (such as t(12;21); t(9;22) or t(4;11)) documented in the patient's leukemia cells pre-transplant on a post-transplant evaluation | 2 | [
"Any",
"leukemia-specific",
"marker",
"(",
"such",
"as",
"t",
"(",
"12",
";",
"21",
")",
";",
"t",
"(",
"9",
";",
"22",
")",
"or",
"t",
"(",
"4",
";",
"11",
")",
")",
"documented",
"in",
"the",
"patient",
"'s",
"leukemia",
"cells",
"pre-transplant"... | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0
] |
NCT01379573 | 1:12:chronic_disease | heterotaxia | 2 | [
"heterotaxia"
] | [
2
] |
NCT01990209 | 20:36:cancer,58:65:cancer,,116:128:treatment,132:177:treatment | Previously treated brain metastases are allowed provided lesions are stable for at least 3 months as documented by head CT scan or magnetic resonance imaging (MRI) of the brain | 2 | [
"Previously",
"treated",
"brain",
"metastases",
"are",
"allowed",
"provided",
"lesions",
"are",
"stable",
"for",
"at",
"least",
"3",
"months",
"as",
"documented",
"by",
"head",
"CT",
"scan",
"or",
"magnetic",
"resonance",
"imaging",
"(",
"MRI",
")",
"of",
"t... | [
0,
0,
3,
3,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT02146924 | 54:68:chronic_disease | Research participants without clinically significant encephalopathy/new focal deficits | 2 | [
"Research",
"participants",
"without",
"clinically",
"significant",
"encephalopathy/new",
"focal",
"deficits"
] | [
0,
0,
0,
0,
0,
2,
0,
0
] |
NCT02435069 | 1:16:chronic_disease | cardiac disease | 2 | [
"cardiac",
"disease"
] | [
2,
2
] |
NCT02856412 | 1:17:chronic_disease | systemic illness affecting central nervous system (CNS) function | 2 | [
"systemic",
"illness",
"affecting",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"function"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.